Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jul 28, 2008; 14(28): 4535-4539
Published online Jul 28, 2008. doi: 10.3748/wjg.14.4535
Published online Jul 28, 2008. doi: 10.3748/wjg.14.4535
Table 1 Baseline characteristics of 1024 participants
| Celecoxib, n (%) | Placebo, n (%) | P | |
| Male | 238 (46.58) | 235 (45.81) | 0.81 |
| Age (yr, means ± SD) | 52.94 ± 6.51 | 52.93 ± 6.48 | 0.97 |
| Smoking | 146 (28.57) | 142 (27.68) | 0.75 |
| Drinking | 172 (33.66) | 175 (34.11) | 0.88 |
| Hypertension | 155 (30.33) | 160 (31.19) | 0.77 |
- Citation: Feng GS, Ma JL, Wong BC, Zhang L, Liu WD, Pan KF, Shen L, Zhang XD, Li J, Xia HH, Li JY, Lam SK, You WC. Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention. World J Gastroenterol 2008; 14(28): 4535-4539
- URL: https://www.wjgnet.com/1007-9327/full/v14/i28/4535.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.4535